Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis

Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis

In remitting–relapsing multiple sclerosis (RR-MS), relapses are driven by autoreactive immune cells that enter the brain and spinal cord and damage myelin sheaths of axons in white and grey matter, whereas during remissions myelin is repaired by activated oligodendroglial cells. Disease-modifying th...

Full description

Bibliographic Details
Main Authors: Paweł Grieb, Maciej Świątkiewicz, Agnieszka Kamińska, Anselm Jünemann, Robert Rejdak, Konrad Rejdak
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Pharmaceuticals
Subjects:
citicoline
multiple sclerosis
demyelination
remyelination
Online Access:https://www.mdpi.com/1424-8247/14/4/326

Similar Items

Similar Items